Skip to main content
Publications
Shih JY, Lin SH, Nagar SP , Davis KL , Jimenez MI , Kahangire DA, Servidio L, Ho L, Veluswamy R. Treatment patterns in resectable early-stage NSCLC in Taiwan: subgroup analysis of a global real-world study . Poster presented at the 2022 ESMO Asia Congress; December 2, 2022. Singapore, Republic of Singapor.
Talbird S , Graham J , Anderson S , Nossov M, Beattie N, Lains Sousa C, Rak A, Masters III H, Diaz-Mitoma F. Cost-effectiveness and epidemiological impact of a novel 3-antigen vaccine for the prevention of Hepatitis B in adults in the United Kingdom . Poster presented at the ISPOR Europe 2022; November 8, 2022. Vienna, Austria. doi: 10.1016/j.jval.2022.09.782
Fernandez M, Bell TJ, Khan S , Tumminello B, Bektas M , Heyes CE , Oton AB. Burden of illness of desmoid tumors . Poster presented at the 2022 CTOS Annual Meeting; November 16, 2022. Vancouver, Canada. Previously presented at the 2022 Desmond Tumor Research Foundation (DTRF) Annual Meeting.
Bali V, Schelfhout J, Sher M, Peters A, Patel G, Mayorga M , (DeMuro) Romano C . Patient-reported symptoms, impacts, and treatment preferences in refractory or unexplained chronic cough: a qualitative study . Poster presented at the 2022 Advancing Allergy & Immunology Care (ACAAI) Annual Scientific Meeting; November 13, 2022. Louisville, KY.
Mathes J , Gill E , Miller R. Visualize the story: a process for creating infographics . Poster presented at the 2022 American Medical Writers Association (AMWA) Conference; November 2, 2022. Denver, CO. Previously presented at the 2022 Virtual American Medical Writers Association (AMWA) Carolina Chapter Spring Conference.
Xu X, Kwiatek J, Chehade M, Aceves S, Maslova E, Kielar D, Stirnadel-Farrant H, Meyers J , Candrilli S , Katial R. Characteristics of and healthcare cost drivers among U.S. patients with eosinophilic esophagitis with high versus non-high all-cause costs: an analysis of insurance claims data . Poster presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting; October 24, 2022. Charlotte, NC.
Hsu RK, Phoenix J, Sinclair GI, Gupta SK, Puga A, Nguyen K, Schubert CK, Merrill D, Richardson D , Nelson K , Reynolds M , Zografos L , Jean-Louis A, Garris C. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND) . Poster presented at the IDWeek 2022 Conference; October 21, 2022. Washington, DC.
Armstrong A, Jayade S, Rege S, Joshi N, Patel V, Davidson D, Kalirai S, Wolin D , Boyle K , Patel D, Seigel L. Evaluating treatment choice among patients with moderate or severe psoriasis . Poster presented at the 2022 Fall Clincial Dermotology Conference; October 20, 2022. Las Vegas, NV.
Djibo DA, Margulis AV , McMahill-Walraven CN, Saltus C , Shuminski P, Kaye JA, Johannes C , Caligaert B , Libertin M, Graham S. Performance of endometrial cancer case finding algorithms among women with select comorbidities in US claims data . Poster presented at the 2022 North American Menopause Society Meeting; October 13, 2022. Atlanta, GA.
Veluswamy R, Ahn MJ, Nagar S , Affi R, Agulnik J, Shih JY, Hochmair MJ, Tufman A, Debieuvre D, Jimenez MI , Davis K , Kahangire DA, Servidio L, di Perna C, Lin SH. Surgical resection, treatment patterns and outcomes in patients (pts) with early-stage non-small cell lung cancer (NSCLC): interim analysis of a global real-world study . Poster presented at the 2022 International Thoracic Surgical Oncology Summit; September 30, 2022. New York, NY.
Spira A, Zhou X , Liao L, Yu E, Chen L, Lau A, Wang Y, Gnanasakthy A , Radford J, Hamadani M. Health-related quality of life and tolerability in patients with/without skin toxicity during loncastuximab tesirine treatment in a phase 2 clinical trial (LOTIS-2) . Poster presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022); September 28, 2022. Houston, TX.
Wainberg ZA, Enzinger PC, Qin S, Yamaguchi K, Gnanasakthy A , Taylor K, Jamotte A, Majer I, Kang YK. Health-related quality of life (HRQoL) in FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer (G/GEJC): results from the FIGHT trial comparing bemarituzumab (BEMA) + modified FOLFOX6 (mFOLFOX6) to placebo (PBO) + mFOLFOX6 . Poster presented at the 2022 ESMO Annual Conference; September 9, 2022. Paris, France.
Saigi-Morgui N , Rebordosa C , Plana E , Rubino A, Aguado J , Martinez D , Lei A, Daoud SZ, McMahon P, Perez-Gutthann S , Rivero-Ferrer E . Acute myocardial infarction, stroke, and MACE in COPD patients treated with aclidinium and other inhaled bronchodilators . Poster presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Garcia de ALbeniz X , Polo R, Teran C, Morales M, Rial-Crestelo D, Garcinuno MA, Garcia del Toro M, Hita C, Gomez-Sirvent JL, Buzon L, Diaz de Santiago A, Perez JL, Sanz J, Bachiller P, Martinez E, Diaz-Brito V, Masia M, Hernandez-Torres A, Guerra J, Arazo P, Arribas J, Martinez de Salazar P, Moreno S, Hernan MA, Del Amo J. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers. A randomized clinical trial . Poster presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Perdrizet J, Horn EK, Hayford K, Grant L, Barry R, Huang L, McDade C , Wilson M . Estimating the historical population-level impact of PCV13 national immunization programs on invasive pneumococcal disease in Australia, Canada, Israel, England & Wales, and the United States . Poster presented at the ISPPD-12 (International Society of Pneumonia and Pneumococcal Diseases); June 19, 2022. Toronto, Canada.
Perdrizet J, Horn EK, Hayford K, Grant L, Barry R, Huang L, McDade C , Wilson M . Non-vaccine serotype population-level trends for invasive pneumococcal disease in Australia, Canada, Israel, England & Wales, and the United States . Poster presented at the ISPPD-12 (International Society of Pneumonia and Pneumococcal Diseases); June 19, 2022. Toronto, Canada.
Diez-Campelo M, Yucel A, Goyal R , Parikh R , Dhuliawala S, Jimenez M , Sluga-O'Callaghan M , Hughes C, Tang D, Germing U. Systemic therapy utilization and hematologic outcomes in lower-risk myelodysplastic syndromes (LR-MDS): findings from a real-world medical record review study in the US, UK, and Europe (EU) . Poster presented at the 2022 European Hematology Association Hybrid Congress; June 10, 2022. Vienna, Austria.
Spira A, Liao L, Zhou X , Gnanasakthy A , Chen L, Ungar D, Yu E, Kilavuz T, Radford J, Hamadani M. Health-related quality of life and tolerability of loncastuximab tesirine in high-risk patients with relapsed/refractory diffuse large B-cell lymphoma treated in a phase 2 clinical trial (LOTIS 2) . Poster presented at the 2022 EHA Congress; June 9, 2022. Vienna, Austria.
Lin SH, Ahn M, Nagar S , Affi R, Agulnik J, Shih J, Hochmair MJ, Tufman A, Debieuvre D, Jimenez MI , Davis K , Kahangire DA, Servidio L, Veluswamy R. Treatment patterns and outcomes in resectable early stage NSCLC: interim analysis of a global real-world study . Poster presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting; June 3, 2022. Chicago, IL.